CEA like substance in cystic fluid of craniopharyngioma
Aoki, M.; Takeuchi, J.; Handa, H.
Nihon Geka Hokan. Archiv für Japanische Chirurgie 52(2): 218-231
1983
ISSN/ISBN: 0003-9152 PMID: 6625822 Document Number: 197439
Document emailed within 1 workday
Related Documents
Oh, S.Y. 1973: Rickham-valve drainage in recurrent cystic craniopharyngioma Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 113(1): 57-72Pajor, A.; Gróf, J.; Idei, M.; Menyhárt, J.; Zsolnai, B. 1982: Utero-inhibin: a new substance inhibiting uterine contraction, isolated from amniotic fluid Acta Physiologica Academiae Scientiarum Hungaricae 59(4): 325-328
Mashimoto, H.; Kaku, M.; Araki, J.; Asai, S.; Takada, T.; Kubota, H.; Matsuo, T.; Ikeda, T. 1989: A case of thymic cyst with elevated CEA in the cystic fluid Nihon Kyobu Shikkan Gakkai Zasshi 27(9): 1087-1091
Mrugacz, M.łg.; Zelazowska, B.; Bakunowicz-Lazarczyk, A.; Wysocka, J.; Minarowska, A. 2005: IFN-gamma in tear fluid in patients with cystic fibrosis Klinika Oczna 107(4-6): 287-288
Tsuji, H.; Furukawa, M.; Sakai, A.; Miyashita, M.; Sasaki, M.; Tokunaga, Y.; Sano, S.; Kanda, S.; Fujii, H.; Mine, Y. 2000: A case of mediastinal mature teratoma accompanying elevated CA 19-9 and CEA in the cystic fluid Kyobu Geka. Japanese Journal of Thoracic Surgery 53(2): 158-161
Jandová, A.; Laurová, L.; Janousková, M.; Novotná, J.; Pezlarová, J.; Skoda, V.; Trnka, V. 1977: LDH/L-lactate: NAD+ oxidoreductase (E.C.1.1.1.27) activity in the cystic fluid of benign and malignant ovarian tumours Acta Universitatis Carolinae. Medica. Monographia 1977(78 Part 2): 121-123
Pauluzzi, S.; Dottorini, S. 1972: Hydatid antigens. I. Chemico-physical analysis of the chromatographic fractions of the cystic fluid Bollettino dell'Istituto Sieroterapico Milanese 51(2): 130-135
Ono, Y.; Sawa, Y.; Yokoyama, H.; Yoshida, T.; Tomita, R.; Mimoto, H.; Azuma, K. 1996: Matured mediastinal teratoma with high levels of tumor markers in cystic fluid Nihon Kyobu Shikkan Gakkai Zasshi 34(12): 1359-1363
Stambolis, C. 1979: Benign multilocular cystic nephroma versus cystic nephroblastoma. a review and classification of cystic metanephric neoplasms Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 123(4): 361-364
Tsvetanova, E.M.; Tsekov, K.T.; Kamenova, M.A.; Gotsev, R.K. 1990: Tumor cells in the cerebrospinal fluid and cystic contents in patients with primary and secondary brain tumors Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(12): 38-42
Abernathy, R.S. 1976: Bulging fontanelle as presenting sign in cystic fibrosis. Vitamin A metabolism and effect on cerebrospinal fluid pressure American Journal of Diseases of Children 130(12): 1360-1362
Landheim, A.S.; Bakken, K.; Vaglum, P. 2006: What characterizes substance abusers who commit suicide attempts? Factors related to Axis i disorders and patterns of substance use disorders. a study of treatment-seeking substance abusers in Norway European Addiction Research 12(2): 102-108
Ardizzoja, M.; Masera, R.G.; Tacconis, P.; Sartori, M.L.; Arisio, R.; Massobrio, M.; Angeli, A. 1994: Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid Anticancer Research 14(2A): 555-559
Hasumi, K.; Kobayashi, S.; Hazato, T.; Hase, K.; Kaya, K. 1989: A study of the leucine enkephalin like substance and enkephalin degrading enzyme activity in human cerebrospinal fluid Masui. Japanese Journal of Anesthesiology 38(9): 1177-1180
Rettori, V.; Van Sickle, M.; Steinberger, A.; Asch, R.H. 1984: Follicle stimulating hormone binding inhibiting activity and inhibin properties of human ovarian cystic and porcine follicular fluid Acta Europaea Fertilitatis 15(2): 93-97
Wahlberg, K.; Høyer-Hansen, G.; Casslén, B. 1998: Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer Cancer Research 58(15): 3294-3298
Yaksh, T.L.; Sabbe, M.B.; Lucas, D.; Mjanger, E.; Chipkin, R.E. 1991: Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates Journal of Pharmacology and Experimental Therapeutics 256(3): 1033-1041
Secreto, G.; Recchione, C.; Fariselli, G.; Grignolio, E.; Di Pietro, S. 1984: Circulating levels and breast cyst fluid concentrations of human chorionic gonadotropin, progesterone and testosterone in women with gross cystic breast disease Tumori 70(6): 523-527
Shoji, M.; Harigaya, Y.; Okamoto, K.; Yamaguchi, H.; Hirai, S. 1988: The study of neuroactive substance within senile plaques--with special reference to somatostatin and substance P Rinsho Shinkeigaku 28(1): 67-73
Nowak, M.A.; Guerriere-Kovach, P.; Pathan, A.; Campbell, T.E.; Deppisch, L.M. 1998: Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression Archives of Pathology and Laboratory Medicine 122(12): 1077-1081